Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vbi Vaccines Inc CS (NQ: VBIV )

2.850 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,810
Open 2.960
Bid (Size) 2.750 (1)
Ask (Size) 2.950 (1)
Prev. Close 2.850
Today's Range 2.720 - 2.980
52wk Range 2.350 - 40.50
Shares Outstanding 8,608,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VBI Vaccines Reports First Quarter 2023 Financial Results
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 345 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-77.86%
-77.86%
1 Month
+6.34%
+6.34%
3 Month
-78.21%
-78.21%
6 Month
-80.42%
-80.42%
1 Year
-89.80%
-89.80%

More News

Read More
Why VBI Vaccines Shares Are Getting Obliterated
Via Benzinga
VBI Vaccines Announces Cost Cutting Measures, Reverse Stock Split
Via Benzinga
VBI Vaccines Earnings Perspective: Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Looking Into VBI Vaccines's Return On Capital Employed
Via Benzinga
VBI Vaccines Appoints Vaughn Himes to Board of Directors
From VBI Vaccines Inc.
Via Business Wire
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
VBI Vaccines Reports Full Year 2022 Financial Results
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B
From VBI Vaccines Inc.
Via Business Wire
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
From VBI Vaccines Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.